» Articles » PMID: 15383670

Establishment of Papillomavirus Infection is Enhanced by Promyelocytic Leukemia Protein (PML) Expression

Overview
Specialty Science
Date 2004 Sep 24
PMID 15383670
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have suggested that most papillomaviruses enter the host cell via clathrin-dependent receptor-mediated endocytosis but have not addressed later steps in viral entry. To examine these events, we followed the localization of L2 and packaged DNA after entry of infectious virions or L1/L2 pseudovirions. Confocal microscopic analyses of HeLa cells showed a time-dependent uncoating of capsids in cytoplasmic vesicles and the accumulation of both L2 and viral DNA at distinct nuclear domains identified as nuclear domain 10 (ND10). Both L2 and the pseudogenome had a punctate distribution and localized to ND10 in promyelocytic leukemia protein (PML)-expressing cells, whereas L2 had a diffuse nuclear distribution in PML-/- cells. The number of pseudovirus-infected cells was an order of magnitude higher in the PML+ cells compared with the PML-/- cells, and viral genome transcription after infection with authentic bovine papillomavirus virions was similarly elevated in PML+ cells. The results identify a role for PML in the enhancement of viral infectivity in the early part of the life cycle. We propose a model in which L2 chaperones the viral genome to ND10 to efficiently initiate viral transcription.

Citing Articles

The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?.

Palomino-Vizcaino G, Banuelos-Villegas E, Alvarez-Salas L Int J Mol Sci. 2024; 25(23.

PMID: 39684702 PMC: 11641362. DOI: 10.3390/ijms252312991.


HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis.

Keiffer T, DiGiuseppe S, Guion L, Bienkowska-Haba M, Zwolinska K, Siddiqa A J Virol. 2024; 99(1):e0093724.

PMID: 39629998 PMC: 11784366. DOI: 10.1128/jvi.00937-24.


The role of HR-HPV integration in the progression of premalignant lesions into different cancer types.

Catalan-Castorena O, Garibay-Cerdenares O, Illades-Aguiar B, Rodriguez-Ruiz H, Zubillaga-Guerrero M, Leyva-Vazquez M Heliyon. 2024; 10(15):e34999.

PMID: 39170128 PMC: 11336306. DOI: 10.1016/j.heliyon.2024.e34999.


Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.

Jain M, Yadav D, Jarouliya U, Chavda V, Yadav A, Chaurasia B Pathogens. 2023; 12(12).

PMID: 38133265 PMC: 10745624. DOI: 10.3390/pathogens12121380.


The interactions between PML nuclear bodies and small and medium size DNA viruses.

Ryabchenko B, Sroller V, Hornikova L, Lovtsov A, Forstova J, Huerfano S Virol J. 2023; 20(1):82.

PMID: 37127643 PMC: 10152602. DOI: 10.1186/s12985-023-02049-4.


References
1.
Bousarghin L, Touze A, Sizaret P, Coursaget P . Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol. 2003; 77(6):3846-50. PMC: 149499. DOI: 10.1128/jvi.77.6.3846-3850.2003. View

2.
Sourvinos G, Everett R . Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells. EMBO J. 2002; 21(18):4989-97. PMC: 126275. DOI: 10.1093/emboj/cdf458. View

3.
Tang Q, Li L, Ishov A, Revol V, Epstein A, Maul G . Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J Virol. 2003; 77(10):5821-8. PMC: 154000. DOI: 10.1128/jvi.77.10.5821-5828.2003. View

4.
Culp T, Christensen N . Quantitative RT-PCR assay for HPV infection in cultured cells. J Virol Methods. 2003; 111(2):135-44. DOI: 10.1016/s0166-0934(03)00170-8. View

5.
Rabe B, Vlachou A, Pante N, Helenius A, Kann M . Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A. 2003; 100(17):9849-54. PMC: 187862. DOI: 10.1073/pnas.1730940100. View